Open AccessNecessity of Antiaggregation and Anticoagulation and Its Prognostic Impact: A Cardiologist’s View
Author(s) -
Ulrich Hink,
Thomas Voigtländer
Publication year - 2020
Publication title -
visceral medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.598
H-Index - 17
eISSN - 2297-475X
pISSN - 2297-4725
DOI - 10.1159/000509896
Subject(s) - medicine , vitamin k antagonist , antithrombotic , atrial fibrillation , cardiology , percutaneous coronary intervention , coronary artery disease , warfarin , myocardial infarction
In modern cardiology, anticoagulation and antiaggregation are key components of current treatment strategies. However, in patients treated with anticoagulation and antiplatelet substances, bleeding is a major risk.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom